LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Aetna’s Denial of ConforMIS Implants Results in Suit
Legal & Regulatory and Reimbursement

Aetna’s Denial of ConforMIS Implants Results in Suit

June 8, 2020 1 min read Premium comments

Advertisement

Aetna’s Denial of ConforMIS Implants Results in Suit
ConforMIS, Pixabay/Clker-Free-Vector-Images, Aetna
#totalkneereplacementSecondary#conformis#aetna

ConforMIS, Inc. and John Michael Schaub, have sued Aetna, Inc. and Aetna Life Insurance Company (Aetna) alleging that Aetna wrongfully denied claims for the use of customized total knee implants for knee replacement patients.

Plaintiffs claim that Aetna violated its duties under the Employee Retirement Income Security Act (ERISA).

According to the complaint, Aetna, a healthcare insurance provider, administers Schaub’s employee-sponsored benefit plan. Schaub, a physical therapist, claims he was wrongfully denied coverage for his ConforMIS iTotal® Knee Replacement System (ConforMIS System).

ConforMIS’ additional claims against Aetna include product disparagement, tortious interference with a contractual relationship, and unfair trade practices.

ConforMIS is a medical technology company that develops, manufactures, and sells customized joint replacement implants. Customized implants are individually sized and shaped to fit each patient. Its main product offering includes the ConforMIS System. The complaint claims the ConforMIS System received Food and Drug Administration (FDA) clearance on February 2, 2011 and has been used in over 100,000 patients.

Plaintiffs allege that for seven years following FDA clearance, Aetna covered the ConforMIS System for total knee replacement. They assert that at no time during this seven-year period did Aetna ever claim “the ConforMIS System to be ineffective, experimental, or investigational.”

On September 21, 2018, plaintiffs claim Aetna stopped covering customized total knee implants. Aetna purportedly revised its policy to describe customized total knee implants as “experimental and investigational because effectiveness has not been established.”

Plaintiffs argue that customized total knee implants are neither experimental nor investigational. In support of their position, plaintiffs provided a history of the ConforMIS System. In addition to FDA clearance, plaintiffs cite Aetna’s own prior approval of the ConforMIS System. Plaintiffs also claim other organizations and providers approve of the system including the American Associate of Hip and Knee Surgeons (AAHKS), United HealthCare, Cigna, and Anthem Blue Cross Blue Shield.

As of the date of this article Aetna had not filed a response.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy